Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-23

Clinical Trial Update: TVMR With the Innovalve System Trial - First In Human Israel [NA]

View source ↗

Summary

Edwards Lifesciences reports completion of the first-in-human TVMR with the Innovalve System trial in Israel for mitral valve regurgitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Edwards Lifesciences | Conditions: Mitral Valve Regurgitation (Degenerative or Functional) | NA | Status: COMPLETED